The estimated Net Worth of Thomas W Erickson is at least $12.5 Million dollars as of 28 November 2023. Mr. Erickson owns over 50,000 units of American Renal Associates stock worth over $9,247,146 and over the last 22 years he sold ARA stock worth over $1,579,526. In addition, he makes $1,670,000 as Independent Director at American Renal Associates.
Sign up
Mr. Erickson ARA stock SEC Form 4 insiders trading
Thomas has made over 12 trades of the American Renal Associates stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of ARA stock worth $265,000 on 28 November 2023.
The largest trade he's ever made was selling 67,500 units of American Renal Associates stock on 27 August 2013 worth over $1,391,850. On average, Thomas trades about 8,313 units every 130 days since 2003. As of 28 November 2023 he still owns at least 257,294 units of American Renal Associates stock.
You can see the complete history of Mr. Erickson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Erickson biography
Thomas W. Erickson serves as Independent Director of the Company. Mr. Erickson also serves as chairman of the executive committee of Luminex Corporation, a developer of biological testing technologies, as a director of syncreon Group Holdings Limited, a transportation logistics services company, and as a director of 3D Systems Corporation, a provider of advanced and comprehensive 3D digital design and fabrication solutions. Mr. Erickson has also held various public company directorships and executive roles, including as chairman of the board and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, interim president and chief executive officer of Luminex Corporation and interim president and chief executive officer of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also chairman of the board of Western Dental Services, Inc., a dental practice management company, and co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Mr. Erickson holds a Bachelors in Business Administration from the University of Iowa and an M.B.A. from Southern Methodist University.
What is the salary of Thomas Erickson?
As the Independent Director of American Renal Associates, the total compensation of Thomas Erickson at American Renal Associates is $1,670,000. There are 1 executives at American Renal Associates getting paid more, with Don Williamson having the highest compensation of $1,772,140.
How old is Thomas Erickson?
Thomas Erickson is 69, he's been the Independent Director of American Renal Associates since 2011. There are no older and 10 younger executives at American Renal Associates.
What's Thomas Erickson's mailing address?
Thomas's mailing address filed with the SEC is 333, Three D Systems Circle, Rock Hill, York County, South Carolina, 29730, United States.
Insiders trading at American Renal Associates
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci und Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
What does American Renal Associates's logo look like?
Complete history of Mr. Erickson stock trades at Luminex Corp, 3D Systems, American Renal Associates und Omega Healthcare Investors
American Renal Associates executives and stock owners
American Renal Associates executives and other stock owners filed with the SEC include:
-
Don Williamson,
Chief Operating Officer, Executive Vice President -
Thomas Erickson,
Independent Director -
Joseph Carlucci,
Chairman of the Board, Chief Executive Officer, Co-Founder -
Syed Kamal,
President, Co-Founder, Director -
John Jureller,
Independent Director -
Michael Boxer,
Independent Director -
Robert Fish,
Independent Director -
Christopher Hocevar,
Independent Director -
Jeremy Gelber,
Independent Director -
Darren Lehrich,
SVP Strategy & Investor Relations -
Jared Hendricks,
Independent Director -
Susanne Clark,
Independent Director -
Mark Herbers,
Interim Chief Financial Officer, Interim Chief Accounting Officer -
Jason Boucher,
Former VP & CFO -
Patrick T Ryan,
Director -
John J Mcdonough,
EVP, COO AND TREASURER -
Michael Ray Costa,
VP and General Counsel -
Jonathan L Wilcox,
VP & Chief Financial Officer -
Victoria Labriola,
VP and General Counsel -
Capital Partners L Pcenterb...,